Mefloquine Disability Evaluations for U.S. Veterans; New Mefloquine Class Action Lawsuit Filed in California; and More

Make Plans To Attend Our Online Annual Meeting; More Successful Mefloquine Claims; Supporter Treks to Mount Everest Base Camp; and More

Injured by Hydroxychloroquine or Related Quinoline Drugs? File Your Claim Now For COVID-Related Compensation

The Quinism Foundation Now Offers Disability Evaluations; The Quinism Foundation Calls on Congress to Fund Research into Mefloquine Neurotoxicity

COVID Has Highlighted the Lasting Dangers of Quinoline Drugs; The VA Continues to Award Additional Mefloquine Ratings; and More

Caution Urged in the Use of Tafenoquine Against COVID-19

FDA Approves Chloroquine and Hydroxychloroquine for Emergency Use Against COVID-19; Online Annual Meeting Update; Russian Mefloquine Disinformation?

Ask Your Senator To Support Research on Quinism; VA Awards Another 100% Mefloquine Rating; GSK Asks for Krintafel® Label Change; Annual Meeting Update

Register Now for our 3rd Annual Meeting, April 27th-28th, 2020; Irish Military Abandons Lariam-or-Nothing Policy; Support The Quinism Foundation

The Quinism Foundation Celebrates Its 2nd Anniversary; Mefloquine Report Expected Soon; New Law May Aid U.S. Veterans Harmed by Tafenoquine

Top General Joins Canadian Mefloquine Lawsuit; The V.A. Continues to Award New Mefloquine Claims; Participate in the U.S. Mefloquine Study

New Mefloquine Study Announced; U.K. Science Media Centre Asked to Correct Inaccurate Information on Mefloquine; Canadian Educational Meeting Update

Register Now for Our 2019 Annual Canadian Educational Meeting

The American Legion Magazine Article on Mefloquine; Support Research and Education on Quinism

The Royal Canadian Legion Grants $25,000 to Support Quinism Education and Research; Are You Among the 1%?; Chris Hrudka's Story

Less than Four Weeks Until Our Annual Meeting — Agenda Announced; Textbook Chapter on Quinism is Published; Are You Among the 1%?

Watch the Second National Academies Meeting Live Today at 9:30 a.m. EDT; Canadian Mefloquine Lawsuit Media Coverage; Recent Foundation Publications

Australian $2.1M Mefloquine & Tafenoquine Veterans Program; Canadian Lawsuit Virtual Town Hall; NASEM Meeting; Six Weeks Until the 2019 Annual Meeting

Only Two Months Until the 2019 Annual Meeting — Make Plans Now to Join Us in White River Junction, Vermont; Canadian Mefloquine Veterans Plan Lawsuits

The 2019 Annual Meeting is Less Than 3 Months Away — Register Now; The VA Disappoints Veterans with the National Academies Study

National Academies to Study Mefloquine; VA Rejects Call to Screen Veterans for Mefloquine Exposure; 2019 Annual Meeting

2018 in Review; Become a Media Ambassador; Make Plans Now to Attend our 2019 Annual Meeting in Vermont

Canadian Firms Plan Mefloquine Legal Action for Veterans; Talking to Your Physician About Mefloquine Poisoning; Plan to Attend Our 2019 Annual Meeting

Roche Sued in California Court for Lariam; Annual Meeting Update; Peace Corps Told to Investigate Mefloquine

VA Misattributing Mefloquine Effects to PTSD; Screening Veterans For Mefloquine Exposure; Mefloquine and the Peace Corps; 2019 Annual Meeting

Roche Abandons Lariam; Mefloquine and the Peace Corps; Visit our New Website; Fundraising Update

Military Mefloquine Documentation; Update Your Subscription

VA Mefloquine Ratings; Chaplain Fluegel's Story

“Adding Mefloquine to An Alzheimer’s Drug is Like Adding Gasoline to a Fire Extinguisher”; Support the Foundation at the 2018 AMSUS Annual Meeting

Partnership with Spartan Wellness; 2018 Annual Canadian Educational Meeting Recap

Partnership with Lifemark Health Group; Balance Awareness Week; 2018 Annual Canadian Educational Meeting

CDC Encouraged to Recommend Against Military Use of Tafenoquine; 2018 Annual Canadian Educational Meeting Update

Register Now for the 2018 Annual Canadian Educational Meeting; Tafenoquine Safety Warnings

U.K. National Centre for Trauma Partners with The Quinism Foundation to Screen Veterans for Symptomatic Mefloquine Exposure